Urinalysis Test Market Expected to Reach $6,121.35 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Urinalysis Test Market," The urinalysis test market valued for $3,194.13 million in 2021 and is estimated to reach $6,121.35 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031. 

 A urinalysis or urine test is a non-invasive procedure to check the composition of urine and detecting some types of medical conditions such as diabetes, urinary tract infection, and kidney-related diseases. This test is also used in pregnancy testing to check the human chorionic gonadotropin (hCG), in the blood or urine. The results of a urinalysis test provide valuable information about a person's health, including the presence of infections, kidney diseases, or other medical conditions affecting the urinary system. These tests are increasingly being used in non-clinical settings, such as workplace drug testing, and sports medicine. This is expected to drive the demand for urinalysis tests and expand the market.  

Urinalysis involves the physical, chemical, and microscopic examination of urine. A urinalysis test can be performed using a device or tool to examine a urine sample for diagnostic purposes. It includes products such as urine strips, chemical reagents, and automated analyzers that perform physical, chemical, and microscopic examinations of urine samples. Urinalysis is a commonly used point-of-care test in clinics, hospitals, and home care.  

Moreover, increase in awareness about the importance of early diagnosis and management of chronic diseases are the upcoming urinalysis test market trends Technological advancements in urinalysis testing have led to the development of more accurate and reliable diagnostic tools, which have further increased the demand for urinalysis tests. Furthermore, growing awareness of preventive healthcare, which includes regular health screenings and checkups such as urinalysis test expected to drive the growth of the urinalysis test market.   

In addition, increase in trend towards home-based medical testing shows significant opportunities for growth of the urinalysis test market. The development of home-based urinalysis testing devices offers a convenient and cost-effective option for patients to monitor their health status which further drive the urinalysis test market forecast.  

Depending on the product, the market is classified into consumables and instruments. The consumables segment contributed largest urinalysis test market share in 2021 and is also expected to witness significant growth during the forecast period owing to, high adoption of consumables such as reagents and strips for urinalysis test. In addition, rise in the technological advancements in urinalysis consumables further boost the segment growth. For instance, Siemens AG offer the Multistix 10 SG Reagent Strips which includes 10 parameters in single strip that provide reliable front-line screening and monitoring for chronic-disease management.  

Depending on application, the urinalysis test market analysis is divided into disease screening and pregnancy & fertility. The disease screening segment accounted for the largest urinalysis test market share in 2021 and is also expected to witness highest CAGR during the forecast period. This is attributed to a rise in adoption of urinalysis devices for disease screening. In addition, rise in prevalence of chronic diseases such as diabetes and kidney disease has led to an increase in demand for urinalysis tests for disease screening purposes. For instance, according to the Centers for Disease Control and Prevention (CDC), more than 1 in 7 (15%) of the U.S. adults or 37 million people t suffered from chronic kidney disease (CKD) in 2021.  

Depending on end user, the market is categorized into hospitals & clinics, diagnostic laboratories, and home care. The diagnostic laboratories segment dominated the urinalysis test market size in 2021, and is also expected to witness highest CAGR during the forecast period. This is attributed to rise in prevalence of chronic diseases such as diabetes and kidney disease has led to an increase in demand for urinalysis tests for diagnostic purposes. In addition, preferable use of diagnostic laboratories in the detection and diagnosis of diseases which further supports the segment growth.   

Region wise, North America was the largest shareholder in the global urinalysis test market size in 2021, owing to, easy availability of products for diagnosis, and well-developed healthcare infrastructure, and rise in awareness about early diagnosis of disease and treatment. In addition, favorable reimbursement policies in healthcare system, and higher adoption of advanced tools for diagnosis purpose drive the market growth in this region.  

However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period, owing to increase in health awareness, development in healthcare infrastructure, and surge in awareness of preventive healthcare in the Asia-Pacific region, which includes regular health check-ups and screening tests.  

Key findings of the study  

• By product type, consumable segment was highest contributor to the urinalysis test industry in 2021.  
• By application, the disease screening segment highest contributor to the urinalysis test industryin 2021.    
• By end user, the diagnostic laboratories segment dominated the market in 2021, and is expected to grow at a CAGR during the forecast period.  
• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.